Status: Not yet recruiting
Efficacy and Safety of Yishen Daluo Yin Granule for Relapsing-Remitting Multiple Sclerosis
The aim of this study is to evaluate the efficacy and safety of YSDLY granule in patients with RRMS. This will be a multi-center, randomized, double-blind, placebo-controlled study.
Participants needed: 152
Trial details
Age: 18-55Biological sex: AllType: InterventionalSponsor: Ying GaoUpdated: Feb 4, 2026
Eligibility criteria
Participants aged 18 to 55 when signing the informed consent, with no gender res... [+6]
According to the 2017 McDonald's guidelines and the 2023 version of the Chinese... [+20]